Treatment of Major Depressive Disorder with Ketamine - retrospective data analysis
- Conditions
- F32Depressive episode
- Registration Number
- DRKS00022836
- Lead Sponsor
- Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
All Patients with Major Depressive Disorder who were treated between 2014 and July 2020 in the Dept. of Psychiatry Freiburg (ward 5) at minimum once with ketamine or esketamine for an individual treatment trial.
The study population comprises about 50 subjects with about 600 single treatments.
Exclusion Criteria
All patients who do not fulfill the inclusion criteria.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of the trial ist getting more insight concerning dosis, kind of application, protocol of treatment, efficacy and side effects in treatment of Major Depressive Disorder with Ketamine.
- Secondary Outcome Measures
Name Time Method